Scynexis (SCYX) Return on Capital Employed Growth (3y) (2017 - 2026)
Scynexis (SCYX) Return on Capital Employed Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 480.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,902.00 |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 18,307.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,307.00 |
| Dec 31, 2025 | 7,148.00 |
| Sep 30, 2025 | 498.00 |
| Jun 30, 2025 | 897.00 |
| Mar 31, 2025 | 2,536.00 |
| Dec 31, 2024 | 762.00 |
| Sep 30, 2024 | -1,441.00 |
| Jun 30, 2024 | -847.00 |
| Mar 31, 2024 | 12,966.00 |
| Dec 31, 2023 | 17,776.00 |
| Sep 30, 2023 | 20,695.00 |
| Jun 30, 2023 | 20,291.00 |
| Mar 31, 2023 | -11,241.00 |
| Dec 31, 2022 | 3,789.00 |
| Sep 30, 2022 | 7,053.00 |
| Jun 30, 2022 | 2,914.00 |
| Mar 31, 2022 | 95.00 |
| Dec 31, 2021 | 434.00 |
| Sep 30, 2021 | 1,211.00 |
| Jun 30, 2021 | 787.00 |